Skip header and navigation
You are here: Library Catalogue Search Search Results
My List: 0 Items
  Revise Search

Narrow By

37 records – page 1 of 2.

Cytomegalovirus (CMV)

https://libcat.nshealth.ca/en/permalink/chpams36606
Nova Scotia Health Authority. Kidney Transplant Clinic. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1999
Available Online
View Pamphlet
The cytomegalovirus (CMV) is a common virus found in people of all ages. People who have had a kidney transplant and are taking immunosuppressive medications are at risk. The pamphlet outlines the symptoms, how the virus is diagnosed, and how it is treated.
More detail
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Kidney Transplant Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([1] p.) : digital, PDF file
Subjects (MeSH)
Cytomegalovirus
Kidney Transplantation - adverse effects
Immunosuppressive Agents - adverse effects
Subjects (LCSH)
Cytomegalovirus infections
Kidneys--Transplantation
Immunosuppressive agents
Specialty
Nephrology
Medications
Abstract
The cytomegalovirus (CMV) is a common virus found in people of all ages. People who have had a kidney transplant and are taking immunosuppressive medications are at risk. The pamphlet outlines the symptoms, how the virus is diagnosed, and how it is treated.
Responsibility
Prepared by: Kidney Transplant Clinic
Pamphlet Number
1999
Less detail

Services de pharmacie d’hôpital

https://libcat.nshealth.ca/en/permalink/chpams36739
Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
2108
Available Online
View Pamphlet
Les Services de pharmacie d’hôpital comptent des pharmaciens et des assistants en pharmacie, qui sont des membres importants de votre équipe de soins de santé. Grâce à leurs connaissances sur les médicaments, ils offrent des soins dans tous les secteurs de la Régie de la santé de la Nouvelle-Écosse (la Régie). La brochure décrit les services offerts, dont la préparation des médicaments, les antécédents pharmaceutiques, la gestion de la pharmacothérapie, les renseignements sur les médicaments, l…
More detail
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Alternate Title
Hospital pharmacy services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
French
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Pharmacy Service, Hospital
Pharmaceutical Services
Subjects (LCSH)
Hospital pharmacies
Pharmaceutical services
Specialty
Medications
Abstract
Les Services de pharmacie d’hôpital comptent des pharmaciens et des assistants en pharmacie, qui sont des membres importants de votre équipe de soins de santé. Grâce à leurs connaissances sur les médicaments, ils offrent des soins dans tous les secteurs de la Régie de la santé de la Nouvelle-Écosse (la Régie). La brochure décrit les services offerts, dont la préparation des médicaments, les antécédents pharmaceutiques, la gestion de la pharmacothérapie, les renseignements sur les médicaments, la promotion de la santé, l’apprentissage, l’enseignement et la recherche, l’information et l’examen des médicaments.
This pamphlet is a French translation of "Hospital Pharmacy Services" pamphlet 1501. The hospital Pharmacy Department includes pharmacists and pharmacy practice assistants, who are important members of your health care team. They offer medication knowledge and care in all areas of Nova Scotia Health Authority (NSHA). This pamphlet describes services offered such as: medical preparation, medication history, medication management, medication teaching, health promotion, learning, teaching, and research, and medication information and review.
Responsibility
Prepared by: Pharmacy Services
Pamphlet Number
2108
Less detail

Bowel preparation for chronic kidney disease before colonoscopy

https://libcat.nshealth.ca/en/permalink/chpams35387
Nova Scotia Health Authority. Renal Program, Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1475
Available Online
View Pamphlet
This pamphlet describes how to get ready for a colonoscopy if you have chronic kidney disease. Steps to prepare solutions on the day before your colonoscopy are listed. The day before your procedure and on the day of the test you should drink only clear liquids, and a suggested list is included. Remember not to eat any food or drink milk, or other liquids that are not clear, on the day before your colonoscopy or on the day of the test.
More detail
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Nova Scotia Health Authority. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Cathartics
Colonoscopy
Renal Insufficiency, Chronic
Subjects (LCSH)
Laxatives
Colonoscopy
Chronic renal failure
Specialty
Medications
Nephrology
Abstract
This pamphlet describes how to get ready for a colonoscopy if you have chronic kidney disease. Steps to prepare solutions on the day before your colonoscopy are listed. The day before your procedure and on the day of the test you should drink only clear liquids, and a suggested list is included. Remember not to eat any food or drink milk, or other liquids that are not clear, on the day before your colonoscopy or on the day of the test.
Responsibility
Prepared by: NSHA Renal Program Educators and Pharmacists
Pamphlet Number
1475
Less detail

Taking your medication

https://libcat.nshealth.ca/en/permalink/chpams34640
Nova Scotia Health Authority. Mental Health and Addictions Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
0758
Available Online
View Pamphlet
Taking your medication is an important part of your treatment. It means you are playing an active role in keeping up your health and well-being. This pamphlet explains why some people stop taking their medication. If these or other issues concern you, please talk to your primary health care provider. They can help you find solutions. Tips to help you take your medication are listed. The French version of this pamphlet 1916, "Prendre vos médicaments", is also available.
More detail
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Mental Health and Addictions Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([1] p.) : digital, PDF file
Subjects (MeSH)
Psychiatry
Medication
Subjects (LCSH)
Drugs
Mental Health
Specialty
Medications
Abstract
Taking your medication is an important part of your treatment. It means you are playing an active role in keeping up your health and well-being. This pamphlet explains why some people stop taking their medication. If these or other issues concern you, please talk to your primary health care provider. They can help you find solutions. Tips to help you take your medication are listed. The French version of this pamphlet 1916, "Prendre vos médicaments", is also available.
Responsibility
Prepared by: Mental Health and Addictions Program
Pamphlet Number
0758
Less detail

Adalimumab therapy for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams35127
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1207
Available Online
View Pamphlet
Your health care provider feels that treatment with adalimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what adalimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
More detail
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
Alternate Title
Adalimumab therapy for IBD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (11 p.) : digital, PDF file
Subjects (MeSH)
Adalimumab
Inflammatory Bowel Diseases - drug therapy
Subjects (LCSH)
Inflammatory bowel diseases
Specialty
Medications
Abstract
Your health care provider feels that treatment with adalimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what adalimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Notes
Previous title: Adalimumab (Humira) therapy
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
1207
Less detail

Polyoma virus and BK virus

https://libcat.nshealth.ca/en/permalink/chpams35425
Nova Scotia Health Authority. Kidney Transplant Clinic. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1510
Available Online
View Pamphlet
BK virus is a part of the polyoma virus family. About 80% of people carry the virus. People usually get this virus as children. It can stay inactive in your body without causing harm for many years. It can become active if you are immunocompromised (your immune system is weak). People who have had a kidney transplant and are taking immunosuppressive medications (medications that suppress [lower] your immune system) are at risk of infection from the virus. This pamphlet explains the symptoms of …
More detail
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Kidney Transplant Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Polyomavirus
BK Virus
Kidney Transplantation - adverse effects
Immunosuppressive Agents - adverse effects
Subjects (LCSH)
Polyomaviruses
Kidneys--Transplantation
Immunosuppressive agents
Specialty
Nephrology
Medications
Abstract
BK virus is a part of the polyoma virus family. About 80% of people carry the virus. People usually get this virus as children. It can stay inactive in your body without causing harm for many years. It can become active if you are immunocompromised (your immune system is weak). People who have had a kidney transplant and are taking immunosuppressive medications (medications that suppress [lower] your immune system) are at risk of infection from the virus. This pamphlet explains the symptoms of BK virus, how BK virus is diagnosed, and how it is treated.
Responsibility
Prepared by: Kidney Transplant Clinic
Pamphlet Number
1510
Less detail

Vedolizumab (Entyvio) therapy

https://libcat.nshealth.ca/en/permalink/chpams35620
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1623
Available Online
View Pamphlet
Vedolizumab (Entyvio®) is given to manage inflammatory bowel disease (IBD), ulcerative colitis, or Crohn's disease. This pamphlet gives you information about vedolizumab to help you make an informed decision about whether or not to use it. Topics include: a brief description of the medicine, who can take it, how it works, how it is given, how long you will need to take it, cost, precautions, and side effects. A list of symptoms to watch out for is listed. Other important things to know when und…
More detail
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (11 p.) : digital, PDF file
Subjects (MeSH)
Gastrointestinal Agents
Colitis, Ulcerative - drug therapy
Crohn Disease - drug therapy
Subjects (LCSH)
Gastrointestinal agents
Ulcerative colitis
Crohn's disease
Specialty
Medications
Abstract
Vedolizumab (Entyvio®) is given to manage inflammatory bowel disease (IBD), ulcerative colitis, or Crohn's disease. This pamphlet gives you information about vedolizumab to help you make an informed decision about whether or not to use it. Topics include: a brief description of the medicine, who can take it, how it works, how it is given, how long you will need to take it, cost, precautions, and side effects. A list of symptoms to watch out for is listed. Other important things to know when undergoing this treatment are provided.
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
1623
Less detail

Aripiprazole (Abilify, Abilify Maintena)

https://libcat.nshealth.ca/en/permalink/chpams35626
Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1627
Available Online
View Pamphlet
Aripiprazole is most often used to treat psychosis. It is also used to treat mania and sometimes depression. This pamphlet explains how to take aripiprazole, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
More detail
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Aripiprazole
Subjects (LCSH)
Antipsychotic drugs
Specialty
Medications
Abstract
Aripiprazole is most often used to treat psychosis. It is also used to treat mania and sometimes depression. This pamphlet explains how to take aripiprazole, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
Responsibility
Prepared by: Pharmacy Services
Pamphlet Number
1627
Less detail

Risperidone (Risperdal, Risperdal Consta)

https://libcat.nshealth.ca/en/permalink/chpams35648
Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1639
Available Online
View Pamphlet
Risperidone is most often used to treat psychosis or mania. It is also used to treat some symptoms of dementia. This pamphlet explains how to take risperidone, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
More detail
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Risperidone
Subjects (LCSH)
Antipsychotic drugs
Specialty
Medications
Abstract
Risperidone is most often used to treat psychosis or mania. It is also used to treat some symptoms of dementia. This pamphlet explains how to take risperidone, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
Responsibility
Prepared by: Pharmacy Services
Pamphlet Number
1639
Less detail

Golimumab (Simponi®) for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams35651
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1641
Available Online
View Pamphlet
Your health care provider feels that treatment with golimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what golimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
More detail
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
Alternate Title
Golimumab (Simponi®) for IBD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (12 p.) : digital, PDF file
Subjects (MeSH)
Golimumab
Inflammatory Bowel Diseases - drug therapy
Subjects (LCSH)
Inflammatory bowel diseases
Specialty
Medications
Abstract
Your health care provider feels that treatment with golimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what golimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Notes
Previous title: Golimumab (Simponi) therapy
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
1641
Less detail

Olanzapine (Zyprexa, Zyprexa Zydis)

https://libcat.nshealth.ca/en/permalink/chpams35690
Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1669
Available Online
View Pamphlet
Olanzapine is most often used to treat psychosis or mania. This pamphlet explains how to take olanzapine, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
More detail
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Antipsychotic Agents
Bipolar Disorder - drug therapy
Schizophrenia - drug therapy
Subjects (LCSH)
Antipsychotic drugs
Manic-depressive illness
Schizophrenia--Treatment
Specialty
Medications
Abstract
Olanzapine is most often used to treat psychosis or mania. This pamphlet explains how to take olanzapine, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
Responsibility
Prepared by: Pharmacy Services
Pamphlet Number
1669
Less detail

Ustekinumab (Stelara) therapy

https://libcat.nshealth.ca/en/permalink/chpams35722
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1695
Available Online
View Pamphlet
Your IBD health care provider believes treatment with a medication called ustekinumab may help to manage your inflammatory bowel disease (IBD). The brand name for ustekinumab is Stelara®. This pamphlet will give you basic information about ustekinumab to help you make an informed decision about whether or not to use this treatment. Topics include what ustekinumab is, how it works, how it is given, how long you will need to take it, and how much it will cost. Considerations before you start taki…
More detail
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (10 p.) : digital, PDF file
Subjects (MeSH)
Ustekinumab
Inflammatory Bowel Diseases - drug therapy
Subjects (LCSH)
Inflammatory bowel diseases
Crohn's disease
Ulcerative colitis
Specialty
Medications
Abstract
Your IBD health care provider believes treatment with a medication called ustekinumab may help to manage your inflammatory bowel disease (IBD). The brand name for ustekinumab is Stelara®. This pamphlet will give you basic information about ustekinumab to help you make an informed decision about whether or not to use this treatment. Topics include what ustekinumab is, how it works, how it is given, how long you will need to take it, and how much it will cost. Considerations before you start taking ustekinumab and while you are taking it are listed. Possible side effects, information about pregnancy and breast/chest feeding, and other important things to know are included.
Notes
Previous title: Ustekinumab (Stelara) therapy for Crohn's disease
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
1695
Less detail

Timbre de nitroglycérine

https://libcat.nshealth.ca/en/permalink/chpams36474
Nova Scotia Health Authority. Pharmacy Department. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1911
Available Online
View Pamphlet
Ce document explique à quoi sert ce médicament et comment le prendre. Vous y découvrirez également ce qu’il faut faire si vous oubliez une dose, des conseils de conservation, des conseils sur les médicaments et les aliments à éviter et des avertissements. Il indique aussi les effets secondaires graves qui nécessitent une visite chez le médecin. ; This pamphlet is a French translation of "Nitroglycerin Patch" pamphlet 0251. This pamphlet explains what this medication is used for and how to take …
More detail
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Department
Alternate Title
Timbre de nitro
Nitroglycerin patch
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
French
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Nitroglycerin
Subjects (LCSH)
Nitroglycerin
Specialty
Medications
Abstract
Ce document explique à quoi sert ce médicament et comment le prendre. Vous y découvrirez également ce qu’il faut faire si vous oubliez une dose, des conseils de conservation, des conseils sur les médicaments et les aliments à éviter et des avertissements. Il indique aussi les effets secondaires graves qui nécessitent une visite chez le médecin.
This pamphlet is a French translation of "Nitroglycerin Patch" pamphlet 0251. This pamphlet explains what this medication is used for and how to take it.
Responsibility
Prepared by: Pharmacy Department
Pamphlet Number
1911
Less detail

Warfarin sodium

https://libcat.nshealth.ca/en/permalink/chpams36501
Nova Scotia Health Authority. QEII. Pharmacy Services, Nova Scotia Health Authority. QEII. Hematology Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
0373
Available Online
View Pamphlet
Warfarin sodium is a type of medication called an oral (by mouth) anticoagulant. An anticoagulant makes your blood less likely to clot (thicken into a clump). This medication helps to prevent and treat abnormal blood clotting. This pamphlet explains what warfarin sodium is, why you may need it, how to take it, and what to do if you miss a dose. Information about INR blood tests, drug and food interactions, possible side effects, and safety precautions is included. Contact information for the An…
More detail
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Pharmacy Services
Nova Scotia Health Authority. QEII. Hematology Services
Alternate Title
Coumadin
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Warfarin
Anticoagulants
Subjects (LCSH)
Warfarin
Anticoagulants (Medicine)
Specialty
Medications
Abstract
Warfarin sodium is a type of medication called an oral (by mouth) anticoagulant. An anticoagulant makes your blood less likely to clot (thicken into a clump). This medication helps to prevent and treat abnormal blood clotting. This pamphlet explains what warfarin sodium is, why you may need it, how to take it, and what to do if you miss a dose. Information about INR blood tests, drug and food interactions, possible side effects, and safety precautions is included. Contact information for the Anticoagulation Clinic and the Thrombosis Anticoagulation Program is provided. The French translation of this pamphlet 2063, "Warfarine sodique" is also available.
Notes
Previous title: Warfarin sodium, an oral anticoagulant
Responsibility
Prepared by: Pharmacy Services and Hematology Services, QEII
Pamphlet Number
0373
Less detail

Cytotoxic precautions at home

https://libcat.nshealth.ca/en/permalink/chpams37335
Nova Scotia Health. Nova Scotia Cell Therapy and Transplant Program. Halifax, NS: Nova Scotia Health Cancer Care Program , 2022.
Pamphlet Number
4037
Available Online
View Pamphlet
You are being treated with a cancer treatment that is cytotoxic. This means it can kill cancer cells and can harm healthy cells. This booklet describes what you, your family, friends and caregivers need to know about cytotoxic precautions. These precautions are used to keep your family members, friends and caregivers safe while you are taking your cancer treatment. This pamphlet explains what cytotoxic precautions are, what body fluids are cytotoxic, how to handle your body wastes, what to do …
More detail
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health. Nova Scotia Cell Therapy and Transplant Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Cancer Care Program
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Neoplasms - drug therapy
Patient Safety
Cytotoxins--toxicity
Subjects (LCSH)
Cancer--Chemotherapy
Patient safety
Specialty
Cancer Care
Medications
Abstract
You are being treated with a cancer treatment that is cytotoxic. This means it can kill cancer cells and can harm healthy cells. This booklet describes what you, your family, friends and caregivers need to know about cytotoxic precautions. These precautions are used to keep your family members, friends and caregivers safe while you are taking your cancer treatment. This pamphlet explains what cytotoxic precautions are, what body fluids are cytotoxic, how to handle your body wastes, what to do if your body wastes spill and what to do with the garbage. Information about dishes, laundry, sex, having a baby, breastfeeding, and how to bring samples to the hospital is included.
Responsibility
Prepared by: Nova Scotia Cell Therapy and Transplant Program
Pamphlet Number
4037
Less detail

Methadone for opioid use disorder

https://libcat.nshealth.ca/en/permalink/chpams37548
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2259
Available Online
View Pamphlet
Methadone is a medication used to treat opioid use disorder. It is long-acting, which means it is slowly released in the body over a long time. This pamphlet explains how to take this medication, how fast methadone starts to work, how your health care team will find the right dose for you, and how long you will need to take methadone. Information about interactions with other medications and possible side effects is included.
More detail
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Methadone
Subjects (LCSH)
Methadone hydrochloride
Specialty
Medications
Abstract
Methadone is a medication used to treat opioid use disorder. It is long-acting, which means it is slowly released in the body over a long time. This pamphlet explains how to take this medication, how fast methadone starts to work, how your health care team will find the right dose for you, and how long you will need to take methadone. Information about interactions with other medications and possible side effects is included.
Responsibility
Prepared by: Pharmacy Services, Aberdeen Hospital
Pamphlet Number
2259
Less detail

Benzodiazepines for alcohol withdrawal

https://libcat.nshealth.ca/en/permalink/chpams37554
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2262
Available Online
View Pamphlet
Benzodiazepines are a group of medications that work as sedatives. They are commonly called “benzos”. Diazepam and lorazepam are 2 benzodiazepines used to manage all stages of alcohol withdrawal. This pamphlet explains how to take this medication, how benzodiazepines help, how your prescriber will decide which benzodiazepine is right for you, how much medication you will need, and possible side effects.
More detail
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Benzodiazepines
Alcohol-Related Disorders - therapy
Alcoholism - drug therapy
Subjects (LCSH)
Benzodiazepines
Alcoholism--Treatment
Specialty
Medications
Abstract
Benzodiazepines are a group of medications that work as sedatives. They are commonly called “benzos”. Diazepam and lorazepam are 2 benzodiazepines used to manage all stages of alcohol withdrawal. This pamphlet explains how to take this medication, how benzodiazepines help, how your prescriber will decide which benzodiazepine is right for you, how much medication you will need, and possible side effects.
Responsibility
Prepared by: Pharmacy Services, Aberdeen Hospital
Pamphlet Number
2262
Less detail

Naltrexone for alcohol use disorder

https://libcat.nshealth.ca/en/permalink/chpams37555
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2263
Available Online
View Pamphlet
Naltrexone is a medication used to help manage alcohol dependence. This medication works on the reward pathways in the brain by lowering the good feeling you get from drinking alcohol. Naltrexone may help you drink less. This pamphlet explains how to take this medication, how well naltrexone works, whether naltrexone interacts with other medications, what will happen if you drink alcohol while taking naltrexone, how long you will need to take naltrexone, possible side effects, and how much nalt…
More detail
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Naltrexone
Alcohol-Related Disorders - therapy
Alcoholism - drug therapy
Subjects (LCSH)
Naltrexone
Alcoholism--Treatment
Specialty
Medications
Abstract
Naltrexone is a medication used to help manage alcohol dependence. This medication works on the reward pathways in the brain by lowering the good feeling you get from drinking alcohol. Naltrexone may help you drink less. This pamphlet explains how to take this medication, how well naltrexone works, whether naltrexone interacts with other medications, what will happen if you drink alcohol while taking naltrexone, how long you will need to take naltrexone, possible side effects, and how much naltrexone costs.
Notes
Previous title: Naltrexone for alcohol dependence
Responsibility
Prepared by: Pharmacy Services, Aberdeen Hospital
Pamphlet Number
2263
Less detail

Buprenorphine for opioid use disorder

https://libcat.nshealth.ca/en/permalink/chpams37561
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2267
Available Online
View Pamphlet
Buprenorphine is a medication used to treat opioid use disorder. It is long-acting, which means it is slowly released in the body over a longer time. This pamphlet explains how to take this medication, how fast buprenorphine starts to work, how your health care team will find the right dose for you, and how long you will need to take buprenorphine. Information on whether buprenorphine interacts with any other medications and possible side effects is included.
More detail
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Buprenorphine
Opioid-Related Disorders - therapy
Subjects (LCSH)
Buprenorphine
Opioid abuse
Specialty
Medications
Abstract
Buprenorphine is a medication used to treat opioid use disorder. It is long-acting, which means it is slowly released in the body over a longer time. This pamphlet explains how to take this medication, how fast buprenorphine starts to work, how your health care team will find the right dose for you, and how long you will need to take buprenorphine. Information on whether buprenorphine interacts with any other medications and possible side effects is included.
Responsibility
Prepared by: Pharmacy Services, Aberdeen Hospital
Pamphlet Number
2267
Less detail

Acamprosate for alcohol use disorder

https://libcat.nshealth.ca/en/permalink/chpams37562
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2268
Available Online
View Pamphlet
Acamprosate is a medication used to help manage alcohol dependence. It works best for people who would like to stop drinking alcohol fully, not just drink less. This pamphlet explains how to take this medication, whether acamprosate interacts with other medications, what will happen if you drink alcohol while taking acamprosate, how long you will need to take acamprosate, possible side effects, and how much acamprosate costs.
More detail
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Acamprosate
Alcohol-Related Disorders - therapy
Alcoholism - drug therapy
Subjects (LCSH)
Acamprosate
Alcoholism--Treatment
Specialty
Medications
Abstract
Acamprosate is a medication used to help manage alcohol dependence. It works best for people who would like to stop drinking alcohol fully, not just drink less. This pamphlet explains how to take this medication, whether acamprosate interacts with other medications, what will happen if you drink alcohol while taking acamprosate, how long you will need to take acamprosate, possible side effects, and how much acamprosate costs.
Notes
Previous title: Acamprosate for alcohol dependence
Responsibility
Prepared by: Pharmacy Services, Aberdeen Hospital
Pamphlet Number
2268
Less detail

37 records – page 1 of 2.